12‐Month Follow‐up After Successful Infliximab Therapy in Pediatric Crohn Disease

Abstract

These data indicate that IFX is efficacious in controlling severe pediatric CD; however, to induce and maintain clinical remission, repeated IFX infusions are required, with a need for dose adjustment in a substantial number of patients.